Financhill
Buy
71

TLSNY Quote, Financials, Valuation and Earnings

Last price:
$5.44
Seasonality move :
0.1%
Day range:
$5.33 - $5.44
52-week range:
$4.53 - $6.71
Dividend yield:
6.86%
P/E ratio:
23.64x
P/S ratio:
1.27x
P/B ratio:
2.02x
Volume:
53.7K
Avg. volume:
70.4K
1-year change:
9.24%
Market cap:
$10.7B
Revenue:
$8.4B
EPS (TTM):
$0.23
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $9.1B $9.7B $10.3B $8.5B $8.4B
Revenue Growth (YoY) -5.47% 7.05% 5.94% -17.33% -1.72%
 
Cost of Revenues $5.7B $6.2B $6.8B $3.2B $3.2B
Gross Profit $3.4B $3.5B $3.5B $5.3B $5.2B
Gross Profit Margin 37.09% 35.94% 33.99% 62.35% 61.96%
 
R&D Expenses $16.1M $32.6M $41.9M -- --
Selling, General & Admin $2.1B $2.3B $2.4B $713.8M $661.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.1B $2.3B $2.5B $6.2B $4.7B
Operating Income $1.3B $1.2B $1B -$912.7M $468.9M
 
Net Interest Expenses $291.1M $344.1M $310M $277.1M $370.4M
EBT. Incl. Unusual Items $990.3M -$2.3B $1.5B -$1.3B $104.4M
Earnings of Discontinued Ops. -$36.1M -$30.5M $20.6M -$25.4M $84.2M
Income Tax Expense $185.6M $151.8M $109.5M $135.1M $103.8M
Net Income to Company $768.7M -$2.5B $1.4B -$1.4B $84.7M
 
Minority Interest in Earnings -$17.7M -$17M -$18.2M -$47.3M -$56.1M
Net Income to Common Excl Extra Items $750.9M -$2.5B $1.4B -$1.5B $28.6M
 
Basic EPS (Cont. Ops) $0.36 -$1.23 $0.67 -$0.72 $0.02
Diluted EPS (Cont. Ops) $0.36 -$1.23 $0.67 -$0.72 $0.02
Weighted Average Basic Share $2.1B $2B $2B $2B $2B
Weighted Average Diluted Share $2.1B $2B $2B $2B $2B
 
EBITDA $3.3B $1.5B $4.7B $3.5B $3.4B
EBIT $1.3B -$1.9B $1.8B -$947.3M $568.1M
 
Revenue (Reported) $9.1B $9.7B $10.3B $8.5B $8.4B
Operating Income (Reported) $1.3B $1.2B $1B -$912.7M $468.9M
Operating Income (Adjusted) $1.3B -$1.9B $1.8B -$947.3M $568.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.4B $2.5B $2B $2B $2.1B
Revenue Growth (YoY) 10.48% 1.27% -18.3% 1.12% 3.01%
 
Cost of Revenues $1.5B $1.6B $727.2M $730.9M $750.3M
Gross Profit $922.5M $858M $1.3B $1.3B $1.3B
Gross Profit Margin 37.93% 34.84% 63.86% 64.08% 64.2%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $562.9M $537.2M -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $563.6M $556.4M $992.6M $981.2M $971.4M
Operating Income $359M $301.6M $292.2M $322.5M $374.1M
 
Net Interest Expenses $80.4M $78.4M $74.6M $105.1M $72.7M
EBT. Incl. Unusual Items $348M $226.6M $219.9M $220.7M $302.3M
Earnings of Discontinued Ops. -- -- $8.5M $16M --
Income Tax Expense $57.5M $38.8M $48.7M $55.2M $60.3M
Net Income to Company $2.6B $2.5B $2.1B $177.6M $256.7M
 
Minority Interest in Earnings -$6M -$5.4M -$16.6M -$15.8M -$18M
Net Income to Common Excl Extra Items $284.5M $182.4M $163.1M $165.9M $224M
 
Basic EPS (Cont. Ops) $0.14 $0.09 $0.08 $0.09 $0.11
Diluted EPS (Cont. Ops) $0.14 $0.09 $0.08 $0.09 $0.11
Weighted Average Basic Share $2B $2B $2B $2B $2B
Weighted Average Diluted Share $2B $2B $2B $2B $2B
 
EBITDA $426.8M $302.5M $719.8M $771.9M $815.5M
EBIT $426.8M $302.5M $292.2M $322.5M $374.1M
 
Revenue (Reported) $2.4B $2.5B $2B $2B $2.1B
Operating Income (Reported) $359M $301.6M $292.2M $322.5M $374.1M
Operating Income (Adjusted) $426.8M $302.5M $292.2M $322.5M $374.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $9.4B $10.4B $9.3B $8.3B $8.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6B $6.8B $4.3B $3.2B $3.2B
Gross Profit $3.4B $3.6B $5B $5.2B $5.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.3B $2.4B -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B $1.6B $4.6B $6.1B $4.6B
Operating Income $1.1B $2B $378.1M -$928.8M $644.6M
 
Net Interest Expenses $312.8M $337.7M $326.8M $305.8M $371.6M
EBT. Incl. Unusual Items $519.3M -$1.5B $721.5M -$1.3B $277.8M
Earnings of Discontinued Ops. -$20.4M $11.6M $8.5M -$5.6M $347.4M
Income Tax Expense $156.4M $151.1M $127.4M $126M $111.5M
Net Income to Company $1.1B -$2.6B $1B -$3.2B $532.1M
 
Minority Interest in Earnings -$18.2M -$15.9M -$56.9M -$42M -$61.9M
Net Income to Common Excl Extra Items $324.3M -$1.6B $545.6M -$1.5B $452.1M
 
Basic EPS (Cont. Ops) $0.16 -$0.78 $0.27 -$0.72 $0.23
Diluted EPS (Cont. Ops) $0.16 -$0.78 $0.27 -$0.72 $0.23
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3.2B $2.9B $5.6B $4.9B $2.9B
EBIT $1.2B -$1.1B $1.1B -$961.3M $743.6M
 
Revenue (Reported) $9.4B $10.4B $9.3B $8.3B $8.4B
Operating Income (Reported) $1.1B $2B $378.1M -$928.8M $644.6M
Operating Income (Adjusted) $1.2B -$1.1B $1.1B -$961.3M $743.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7B $7.7B $6.6B $6.2B $6.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.4B $5B $2.4B $2.3B $2.3B
Gross Profit $2.6B $2.7B $4.2B $3.9B $3.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.7B $1.8B -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.8B $1.1B $3.3B $3.2B $3.1B
Operating Income $798.5M $1.6B $839.6M $687.5M $864.9M
 
Net Interest Expenses $247.1M $241.2M $257.7M $281M $282.3M
EBT. Incl. Unusual Items $333.7M $1.4B $587.7M $414M $588.6M
Earnings of Discontinued Ops. -$20.7M $20.9M $8.5M $42.3M $305.6M
Income Tax Expense $113.1M $111.1M $127.9M $116.5M $124.5M
Net Income to Company $2.6B $2.5B $2.1B $335.1M $782.5M
 
Minority Interest in Earnings -$12.2M -$10.9M -$49.8M -$43.5M -$49.3M
Net Income to Common Excl Extra Items $187.6M $1.3B $418.6M $296.3M $720.7M
 
Basic EPS (Cont. Ops) $0.09 $0.61 $0.21 $0.15 $0.37
Diluted EPS (Cont. Ops) $0.09 $0.61 $0.21 $0.15 $0.37
Weighted Average Basic Share $6.1B $6.1B $6.1B $5.9B $5.9B
Weighted Average Diluted Share $6.1B $6.1B $6.1B $5.9B $5.9B
 
EBITDA $907.8M $1.6B $2.2B $2B $2.2B
EBIT $907.8M $1.6B $839.6M $687.5M $864.9M
 
Revenue (Reported) $7B $7.7B $6.6B $6.2B $6.2B
Operating Income (Reported) $798.5M $1.6B $839.6M $687.5M $864.9M
Operating Income (Adjusted) $907.8M $1.6B $839.6M $687.5M $864.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $654.5M $993.2M $1.6B $659.2M $1.2B
Short Term Investments -- $345.8M $673.9M $221.5M --
Accounts Receivable, Net $1.8B $991.2M $933.8M $885.6M $1.4B
Inventory $210.4M $234.2M $225.5M $280M $229.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $212.8M $330.6M $332.3M $289.9M $283.2M
Total Current Assets $4.3B $4.5B $4.7B $3.6B $5.3B
 
Property Plant And Equipment $10B $10.5B $9.8B $8.8B $8.6B
Long-Term Investments -- -- -- -- --
Goodwill $8.1B $7.7B $7.3B $4.9B $4.3B
Other Intangibles $2.9B $2.9B $2.8B $2.5B $2.5B
Other Long-Term Assets $231.9M $285.4M $268.6M $236.6M $251.6M
Total Assets $28.2B $27.6B $26.2B $21.4B $22.5B
 
Accounts Payable $3B $1.7B $1.9B $1.9B $1.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $326.2M $317.5M $312.9M --
Other Current Liabilities $107K $827.1M $764.9M $666.5M $727.1M
Total Current Liabilities $5.4B $4.9B $4.7B $4.1B $5.4B
 
Long-Term Debt -- $4B $2.6B $7B $7.8B
Capital Leases -- -- -- -- --
Total Liabilities $18.4B $19.9B $17B $14.9B $16.8B
 
Common Stock $2.9B $3.2B $2.9B $2B $2.1B
Other Common Equity Adj -- -- -- -- --
Common Equity $9.7B $7.6B $8.9B $6.2B $5.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $150.8M $136.5M $310.8M $329.5M $350.3M
Total Equity $9.9B $7.8B $9.2B $6.5B $5.7B
 
Total Liabilities and Equity $28.2B $27.6B $26.2B $21.4B $22.5B
Cash and Short Terms $654.5M $1.3B $2.3B $880.8M $1.2B
Total Debt $12.8B $4B $2.7B $7.4B $9.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.4B $1.6B $872.8M $720M $637.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5B $1.5B $1.2B $1.3B $1.3B
Inventory $192.2M $196.4M $239.9M $222.4M $197.7M
Prepaid Expenses -- -- -- -- --
Other Current Assets $243.2M $445.3M $379.6M $359.5M $266M
Total Current Assets $4.9B $4.9B $3.7B $4.6B $3.4B
 
Property Plant And Equipment $9.5B $9.7B $8B $8.1B $8.5B
Long-Term Investments -- -- -- -- --
Goodwill -- $10.2B $8.3B $6.6B $6.4B
Other Intangibles $11B $163.2M $199.5M $280.6M $262.5M
Other Long-Term Assets -- -$113.7K -$89.8K -- $99.2K
Total Assets $27.6B $26.5B $22.2B $21.4B $20.5B
 
Accounts Payable $3.3B $3.9B $3.5B $3.1B $3.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $313.6M $343.4M $285.6M $294.5M $338.9M
Other Current Liabilities -- $227.5K -- $91.6K $99.2K
Total Current Liabilities $4.7B $5.6B $4.3B $4.8B $3.8B
 
Long-Term Debt $3.8B $2.9B $2.8B $3.8B $7.5B
Capital Leases -- -- -- -- --
Total Liabilities $18.7B $18.3B $14.1B $15.5B $14.8B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $127.9M $120.4M $308.4M $338M $368.9M
Total Equity $8.9B $8.2B $8.1B $5.9B $5.7B
 
Total Liabilities and Equity $27.6B $26.5B $22.2B $21.4B $20.5B
Cash and Short Terms $1.4B $1.6B $872.8M $720M $637.5M
Total Debt $4.5B $2.9B $3B $4B $7.7B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $768.7M -$2.5B $1.4B -$1.4B $84.7M
Depreciation & Amoritzation $2B $3.5B $2.9B $4.4B $2.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $280.1M $317.8M $30.3M -$52.2M -$17.6M
Change in Inventories -$10.5M $436.9K -$10.7M -$79.1M $51.2M
Cash From Operations $2.9B $3.1B $3.2B $2.4B $2.3B
 
Capital Expenditures $1.6B $1.5B $1.8B $1.6B $1.5B
Cash Acquisitions -$981.2M $499M $1B $13.7M -$13.9M
Cash From Investing -$3.2B -$354.7M -$1.3B -$990.6M -$2.1B
 
Dividends Paid (Ex Special Dividend) -$1B -$1.1B -$955.6M -$822.7M -$557.1M
Special Dividend Paid
Long-Term Debt Issued $667.8M $1.3B $1.1M $1.6B $1.3B
Long-Term Debt Repaid -$786.5M -$1.7B -$1.1B -$2.4B -$579.5M
Repurchase of Common Stock -$530.7M -$109.4M -$2.5M -$550.5M --
Other Financing Activities -$303.9M -$60.6M $822.8M -$442.6M $151.3M
Cash From Financing -$1.6B -$2.5B -$1.2B -$2.2B $250.6M
 
Beginning Cash (CF) $2.4B $678.3M $973.5M $1.4B $649M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.9B $246.8M $685.6M -$769.1M $497.4M
Ending Cash (CF) $657.4M $910.1M $1.7B $685.1M $1.1B
 
Levered Free Cash Flow $1.3B $1.7B $1.4B $806.9M $869.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.6B $2.5B $2.1B $177.6M $256.7M
Depreciation & Amoritzation -$107.6M -$112.8M -$73.2M -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $962.9M $720.4M $507.9M $681.5M $534.4M
 
Capital Expenditures $403.8M $341.3M $303.3M $276.3M $300.9M
Cash Acquisitions -- -- -- $103.8K $33M
Cash From Investing -$320.9M -$549.1M $12.7M -$230.2M -$300.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$177.4M -$199.7M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -$21.9M $177.7K
Long-Term Debt Repaid -- -- -- -$71.4M -$105.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$119.4M $114.2M
Cash From Financing -$281.7M -$80.5M -$639.1M -$397.4M -$200.2M
 
Beginning Cash (CF) $1B $1.5B $1.1B $689.1M $554.2M
Foreign Exchange Rate Adjustment $3.8M $16.8M -$785.7K $10M $311K
Additions / Reductions $360.3M $90.8M -$118.5M $54M $34.2M
Ending Cash (CF) $1.5B $1.6B $927.2M $736.2M $619.4M
 
Levered Free Cash Flow $559.1M $379.1M $204.5M $405.2M $233.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.1B -$2.6B $1B -$3.2B $532.1M
Depreciation & Amoritzation $1.7B $3.4B $2.9B -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $3B $3.1B $2.5B $2B $2.6B
 
Capital Expenditures $1.5B $1.6B $1.7B $1.7B $1.4B
Cash Acquisitions -- -- -- $3.2M $762.8M
Cash From Investing -$1.1B -$741.1M -$1.2B -$1.9B -$646.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$364.5M -$760.9M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $417.5M
Long-Term Debt Repaid -- -- -- -- -$1.7B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- $20.5M
Cash From Financing -$1.5B -$2.2B -$1.7B -$325.9M -$2.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $402M $139.2M -$408.8M -$217.7M -$120.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.5B $1.5B $884.6M $310.3M $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.6B $2.5B $2.1B $335.1M $782.5M
Depreciation & Amoritzation -$307.6M -$355.2M -$351.3M -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.4B $2.3B $1.7B $1.3B $1.5B
 
Capital Expenditures $1.1B $1.2B $1B $1.1B $992.6M
Cash Acquisitions -- -- -- $3.2M $779.9M
Cash From Investing -$328.9M -$715.3M -$650.7M -$1.5B -$82.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$364.5M -$568.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $899.8M $6.6M
Long-Term Debt Repaid -- -- -- -$321.9M -$1.4B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $174.6M $43.7M
Cash From Financing -$1.3B -$992.7M -$1.5B $349.6M -$2B
 
Beginning Cash (CF) $2.9B $3.6B $3.6B $2.4B $2.1B
Foreign Exchange Rate Adjustment $17.4M $26.3M $16.7M $6.9M $11.5M
Additions / Reductions $742.8M $635.3M -$459M $92.3M -$525.6M
Ending Cash (CF) $3.7B $4.2B $2.9B $2.4B $1.6B
 
Levered Free Cash Flow $1.3B $1.2B $680.7M $184.1M $552M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock